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Abstract:  In  this  study  we  evaluate  the  influences  of  optical  property 
assumptions on near-infrared diffuse correlation spectroscopy (DCS) flow 
index measurements. The optical properties, absorption coefficient (µa) and 
reduced scattering coefficient (µs), are independently varied using liquid 
phantoms and measured concurrently with the flow index using a hybrid 
optical  system  combining  a  dual-wavelength  DCS  flow  device  with  a 
commercial  frequency-domain  tissue-oximeter.  DCS  flow  indices  are 
calculated at two wavelengths (785 and 830 nm) using measured µa and µs 
or assumed constant µa and µs. Inaccurate µs assumptions resulted in much 
greater flow index errors than inaccurate µa. Underestimated/overestimated 
µs from 35%/+175% lead to flow index errors of +110%/80%, whereas 
underestimated/overestimated µa from 40%/+150% lead to 20%/+40%, 
regardless  of  the  wavelengths  used.  Examination  of  a  clinical  study 
involving human head and neck tumors indicates up to +280% flow index 
errors resulted from inter-patient optical property variations. These findings 
suggest  that  studies  involving  significant  µa  and  µs  changes  should 
concurrently  measure  flow  index  and  optical  properties  for  accurate 
extraction of blood flow information. 
© 2011 Optical Society of America 
OCIS codes: (170.0170) Medical optics and biotechnology; (170.3660) Light propagation in 
tissues; (170.3880) Medical and biological imaging; (170.6480) Spectroscopy, speckle. 
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1. Introduction 
Near-infrared (NIR) light has been recently employed in the noninvasive acquisition of blood 
flow information from deep tissues (up to several centimeters), which is referred to as NIR 
Diffuse Correlation Spectroscopy (DCS) [1–4] or Diffuse Wave Spectroscopy (DWS) [5,6]. 
DCS  measures  relative  change  of  tissue  blood  flow  (rBF)  which  has  been  extensively 
validated in various tissues through comparisons with laser Doppler flowmetry (LDF) [7], 
Doppler  ultrasound  [8,9],  power  Doppler  ultrasound  [10,11],  Xenon-CT  [12],  fluorescent 
microsphere measurement [13], arterial spin labeled magnetic resonance imaging (ASL-MRI) 
[14,15], and to literatures [1,4,16–18]. DCS also provides a blood flow index for comparisons 
of longitudinal measurements and inter-subject variations [11,13,19,20]. The probing depth of 
NIR  DCS  (several  centimeters)  is  significantly  larger  than  those  (several  millimeters)  of 
similar  optical  modalities  such  as  LDF  [21–23],  Doppler  optical  coherence  tomography 
(DOCT)  [24],  photoacoustic  tomography  (PAT)  [25],  and  optical  micro-angiography 
(OMAG) [26]. DCS is primarily sensitive to microvasculature rather than large blood vessels 
(e.g., Doppler ultrasound measurement), and does not require radiation exposure (e.g., PET, 
Xenon-CT).  Systems  based  on  DCS  provide  portability,  allowing  for  bedside  monitoring 
utilizing short acquisition time (varying from 6.5 ms to several seconds) without expensive 
instrumentation [17,27–29]. Due to these features, usages of DCS expand continuously into 
new  applications  in  various  deep  organs/tissues  such  as  muscle  [15,28,30–33],  tumor 
[10,11,19,20,29,34–36] and brain [4,5,7–9,12–14,16,17,27,37–41]. 
The  use  of  NIR  light  for  deep  tissue  measurements  stems  from  the  exploitation  of  a 
spectral region (650-950 nm) wherein light absorption of the biological tissue is relatively 
low. When using NIR spectroscopy (NIRS) to detect optical properties of deep tissues, a pair 
of source and detector fibers is usually placed along the tissue surface with a distance of a few 
centimeters. NIR light generated by a laser emits into tissues through the source fiber and is 
detected by a photodetector through the detector fiber. Photon  migration in tissue is now 
known to be a diffusive process [2,7]. During this migration, photons encounter absorption 
and, more commonly, scattering events. The probabilities of these events are described by an 
absorption coefficient, μa, and a reduced scattering coefficient, μs, also referred to as the 
optical properties, intrinsic to the probed tissue volume. The penetration depth of NIR light in 
biological  tissues  is  approximately  half  of  the  source-detector  separation.  NIR  DCS  flow 
measurements are accomplished by monitoring speckle fluctuations of photons emitted at the 
tissue surface. In non-muscular tissues moving red blood cells (RBCs) inside vessels are 
primarily  responsible  for  these  fluctuations  [4,5,7–14,16,17,19,20,27,29,34–42],  but 
complications  such  as  tissue  shearing  and  motion  artifacts  can  arise  for  muscular  tissues 
[28,32].  Blood  flow  indices  and  rBF  can  be  calculated  from  the  changes  in  the  speckle 
patterns. Ensuing calculations of blood flow using DCS measurements include a dependence 
on the optical properties (μa and μs) and are thus potentially influenced by variations thereof 
(see the details in Section 2). 
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coefficients.  Solutions  to  this  issue  have  typically  been  approached  using  two  general 
methods:  optical  property  assumptions  or  optical  property  measurements  with  separate 
instrumentation. Some studies have chosen to use the values of μa and μs from the literature 
[8,32], respective to the tissue type (e.g., brain or muscle), or assumed a constant μs while 
examining changes in μa [13,30,40]. These assumptions may be susceptible to deviations in 
optical properties that occur transiently, longitudinally, due to subject differences or from 
differences in literatures. A few of the recent studies have employed hybrid instrumentation 
allowing  for  measurement  of  both  sets  of  information  to  extract  accurate  blood  flow 
[9,19,29,43]. However, a generalization of potential flow index errors due to the inaccurate 
estimation of optical properties has not been investigated for the DCS flow measurements. In 
addition to optical properties, another potential influence on DCS flow indices is determined 
by selection of the laser wavelength. 
Our lab has recently built a hybrid instrument capable of the simultaneous measurement of 
absolute μa, μs and flow indices at multiple wavelengths, through combining a commercial 
frequency-domain  NIR  tissue-oximeter,  the  Imagent  (ISS,  Inc.,  IL,  USA)  [44,45],  and  a 
custom-made NIR DCS flow-oximeter [31,33,41]. This newly developed hybrid instrument 
allows us to quantify the influences of optical properties on DCS flow indices measured at 
different wavelengths. In this study, homogeneous liquid phantoms with controlled variations 
of optical properties were created, attempting to isolate the influence of each optical property 
parameter  (i.e.,  μa  or  μs)  on  DCS  flow  indices.  The  usage  of  tissue-like  phantoms  for 
instrument calibration and experimental validation of NIRS and DCS techniques is common 
[2,4,44–51].  In  DCS  measurements,  the  dynamic  scatterer  motions  (typically 
microvasculature  RBCs)  are  best  modeled  by  Brownian  diffusion  as  opposed  to  random 
ballistic flow,  which has been determined empirically, but for reasons currently  unknown 
[4,7,8,10,11,20,27,40]. An effective Brownian diffusion coefficient is calculated as the blood 
flow index when measuring in biological tissues and is usually distinct from the conventional 
Brownian diffusion coefficient predicted by Einstein [52]. However, when utilizing liquid 
phantoms with Intralipid particles to provide Brownian motion, the two diffusion coefficients 
are expected to be equivalent. Through this special case using liquid phantoms, DCS flow 
indices  calculated  using  measured  or  assumed  optical  properties  can  be  compared  to  the 
Einstein  prediction  (as  a  true  flow  index)  for  Brownian  particles  suspended  in  liquid. 
Measurement errors are then determined through these comparisons for DCS flow indices at 
different wavelengths. 
Simultaneous measurements of optical properties and blood flow indices are essential for 
extracting accurate hemodynamic information in tissues with transient, longitudinal and inter-
subject  differences  in  optical  properties. To  this  end,  we  show  a  clinical  study  using  the 
hybrid instrument to accurately quantify tissue optical properties and blood flow indices in 
head  and  neck  tumors.  The  measurement  errors  in  tumor  blood  flow  indices  induced  by 
potential  inaccurate  estimations  of  tissue  optical  properties  are  ultimately  discussed  and 
compared to the phantom study results to determine the in vivo applicability thereof. 
2. Methods and materials 
2.1. Diffuse correlation spectroscopy (DCS) for blood flow measurement 
DCS  flow  indices  are  quantified  by  a  dual-wavelength  DCS  system  [31]  with  two  long 
coherence length continuous-wave (CW) NIR laser sources at 785 and 830 nm (100 mW, 
Crystalaser, Inc., NV, USA). The DCS sources emit light alternately into the tissue via two 
multi-mode optical fibers bundled at the same location on the tissue surface (see Fig. 1a). 
Four detector fibers are tightly bundled and placed on the tissue surface at a distance of 1.5 
cm away from the source fibers, and each is connected to a single photon-counting avalanche 
photodiode (APD) (PerkinElmer Inc., Canada). The outputs of 4 APDs are sent to a 4-channel 
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temporal autocorrelation functions (g2) which are averaged to improve the signal-noise-ratio. 
The averaged g2 from DCS is related to the normalized electric field temporal autocorrelation 
function (g1) through the following Siegert relation [53]: 
     
2
21 , 1 , g r g r        (1) 
where  ˄  is  the  delay  time,  r  is  the  position  vector,  and  β depends  on  laser  stability  and 
coherence length and the number of speckles detected. 
 
Fig. 1. (a) Hybrid fiber-optic probe comprised of: two DCS source fibers (785 and 830 nm) and 
four bundled DCS detector fibers separated by a distance of 1.5 cm; eight ISS source fibers 
(780 and 830 nm) and ISS detector fiber separated by distances of 2.0, 2.5, 3.0 and 3.5 cm (2 
source fibers per separation distance). Note that two additional DCS detector fibers are shown, 
at 2.4 and 2.8 cm separations, but were not connected for this study. (b) Cartesian coordinates 
oriented for DCS source and detector (left) and liquid phantom setup (right) including: ~9.5 L 
glass aquarium (30.5 cm x 21.0 cm x 15.0 cm), hybrid optical probe and holder, and lab stand. 
(c) Typical correlation function fitting from a phantom experiment (μa (830 nm) = 0.05 cm
1, 
μs (830 nm) = 10 cm
1) with g1 derived from g2 measurements (g1m) using Eq. (1) and g1 
calculated (g1c) using Eq. (3). 
Scatterer  motion  is  directly  associated  with  the  unnormalized  electric  field  temporal 
autocorrelation function (G1) which obeys a correlation diffusion equation, derived rigorously 
elsewhere [2,46] and defined as follows for homogeneous media using a CW source (steady 
state): 
     
2 ' 2 2
01
1
, ( )
3
as D v v k r G r vS r             

   (2) 
where
' /(3 ) s Dv   is the photon diffusion coefficient, v is the speed of light in the medium, 
2
0 k is the wavenumber,  () Sr is the source light distribution, and  
2 r   is the mean-square 
displacement of scatterers in time ˄. The position vector,  r , denotes a general vector from a 
source  to  a  point  of  detection.  Note  that  G1  is  the  unnormalized  version  of  g1,  i.e., 
      1 1 1 , , / ,0 g r G r G r   . Scatterer movement for particles undergoing Brownian motion 
results in  
2 6 B rD   , where DB is the effective Brownian diffusion coefficient. An α 
(0–1) term is added to account for not all scatterers being dynamic and is defined as the ratio 
of moving scatterers to total scatterers. The combined term, αDB, is referred to as the blood 
flow index in biological tissues and is commonly used to calculate the relative blood flow 
(compared  to  the  baseline  flow  index  before  physiological  changes).  In  contrast  to  tissue 
samples where scatterers may be static (e.g., organelle, mitochondria) or dynamic (moving 
(b) 
(c) 
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α 1 and the flow index is thus reported as simply DB. The homogeneous CW solution to Eq. 
(2) for semi-infinite geometry is 
   
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exp exp
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where  ρ  is  the  source-detector  separation,  S0  is  source  intensity, 
   
2 ' '2 2 2
0 3 a s s K k r          ,   
1/2 2 2
10 r z z       ,   
1/2 2 2
20 2 b r z z z        , 
'
0 1/ s z   ,     
' 2 1 /3 1 b eff s eff z R R     , 
21 1.440 0.710 0.668 0.0636 eff R n n n
       and 
n 1.33 (for tissues and phantoms) [7,46,54,55]. The Reff term accounts for the mismatch 
between the medium and the air indices of refraction with n being the ratio between them. 
For semi-infinite geometry, the collimating laser source at (0, 0, 0) and detector at (ρ, 0, 0) 
are placed on the tissue surface with z = 0 (see Fig. 1b). This solution (Eq. (3)) involves an 
extrapolated zero boundary condition including an isotropic source at z = z0 and negative 
isotropic imaging source at z = (z0 + 2zb). The position vector, r , from Eq. (2) considers the 
point  source  at  (0,  0,  z0)  and  the  negative  imaging  source  at  (0,  0,  (z0  +  2zb)).  The 
superposition of solutions to these two sources using infinite geometry provides the resulting 
Eq. (3) where now the semi-infinite boundary is modeled by the scalar parameter, ρ. Further 
details can be found elsewhere [46,55]. 
Flow index calculations begin with using Eq. (1) to first determine the β. Using the g2 data 
at  earliest  ˄  and  letting  g1  1  (i.e.,       1 1 1 ,0 ,0 / ,0 1 g G G     )  lead  to 
2( , 0) 1 g       . Using DCS  measured  2( , ) g  , calculated β and  Eq. (1),  1( , ) g   is 
calculated for all ˄. Equation (3) is then used with the unknown parameter αDB (flow index) to 
fit the g1 derived from DCS measurements (see Fig. 1c). For a complete frame of DCS data 
acquisitions at two wavelengths, two flow indices are obtained sequentially. 
2.2. Frequency-domain spatially resolved NIRS for tissue optical property measurement 
Quantification  of  absolute  μa  and  μs  is  performed  by  a  frequency-domain  multi-distance 
spatially resolved spectroscopy, i.e., the Imagent. Two wavelengths (780 and 830 nm) of a 
four-wavelength (690, 750, 780 and 830 nm) Imagent system are chosen to match the DCS 
lasers available (785 and 830 nm). The Imagent emits sinusoidally modulated light into tissue 
through 8 optical fibers (4 per wavelength) placed at four pre-determined distances (2.0, 2.5, 
3.0, and 3.5 cm) from a detector fiber bundle connected to a photomultiplier tube (PMT) (see 
Fig. 1a). Source light is modulated at 110 MHz resulting in detected AC, DC and Phase (ˆ) 
information from multiple distances. A simplified solution based on semi-infinite geometry 
for the photon diffusion equation exposes linear relationships between ˆ, logarithmic AC or 
logarithmic DC and spatial distances [44,45]. From the fitting slopes (SAC, SDC, Sˆ) of the 
linear relationships μa and μs can be extracted at each wavelength. Different source-detector 
separations generally provide measurements at different depths/regions based on diffusion 
theory [3]. However, the depth/regional difference has minimal effect on measurement of 
optical properties of homogeneous phantoms. 
2.3. Brownian motion of spherical particles in liquid phantoms 
As  mentioned  earlier,  when  using  liquid  phantoms  with  Intralipid  particles  to  provide 
Brownian motion, the effective Brownian diffusion coefficient (flow index) measured by DCS 
is expected to be equivalent to the conventional Brownian diffusion coefficient predicted by 
Einstein [52]. In the present study, DCS  flow  indices  are compared to Einstein diffusion 
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defined by the Einstein-Stokes formula for spherical particles in liquid is 
 
6
T B
B
k
D
R 
    (4) 
where kB is the Boltzmann constant, T is the phantom temperature, R is the radius of the 
spherical particles and η is the viscosity [52]. In order to obtain the temperature and viscosity 
parameters, a temperature sensor (Physitemp, NJ, USA) is attached near the optical probe and 
viscosity is measured using a viscometer (Brookfield, MA, USA). Viscosity is reported in 
units of cP (centipoise), where 1 cP = 1 mPa∙s (millipascal∙second) = 0.001 kg∙m
1s
1 [56]. 
The radius of Intralipid particles is estimated as 196 nm (see Section 2.5). 
2.4. Liquid phantoms with varied optical properties 
Liquid phantoms are comprised of distilled water, India ink (Black India 44201, Higgins, MA, 
USA) and Intralipid (30%, Fresenius Kabi, Uppsala, Sweden). India ink is used to manipulate 
the absorption coefficient of the phantom, μa (λ), where λ is the laser source wavelength. India 
ink is first diluted to a 10% solution with distilled water. The 10% ink solution (instead of 
pure ink) is used to create phantoms. Intralipid provides particle Brownian motion and control 
of the reduced scattering coefficient of the phantom, μs (λ). Setup of the liquid phantom is 
shown in Fig. 1b. A hybrid fiber-optic probe is placed on the surface of the liquid phantom 
solution contained inside a glass aquarium. A custom-made probe holder attached to a lab 
stand holds the probe at the center of the solution to simulate a semi-infinite geometry. 
For creating phantoms with μa variation, a list of μa (λ) and a constant μs (λ) are chosen 
(see details in Section 2.5). The μa (λ) and μs (λ) of distilled water, 10% ink solution, and 
30%  Intralipid  are  first  determined.  These  values  in  combination  with  titration  equations 
provide the necessary volumes of water, ink and Intralipid to achieve desired phantom optical 
properties  [57].  The  subscripts  “ink”,  “Intralipid”,  and  “water”  are  used  in  this  paper  to 
denote 10% ink solution, 30% Intralipid, and distilled water, respectively. The μa ink (λ) is 
derived from spectrometer (Beckman Coulter, CA, USA) measurements. Since the 10% ink 
solution is out of the measurable range of the spectrometer, further dilution is performed to 
get a 0.025% ink solution for spectrometer absorbance measurements. Absorbance measured 
from multiple 0.025% ink solution samples are averaged and converted to the μa ink (λ) [57]. 
The μa water (λ) is taken from the literature [58]. The μa Intralipid (λ) is assumed to be equivalent to 
that of water. Distilled water and 10% ink solution are both assumed to have no contributions 
to the phantom μs (λ), i.e., μswater (λ) = μsink (λ) = 0 cm
1. The μs (λ) of 10% Intralipid is 
calculated  using  a  Mie  theory  approximation  [59].  The  theory  and  details  including  the 
Intralipid particle radius and refractive index were described in the original derivation [59] 
which  has  been  extensively  used  for  quantification  of  Intralipid-based  liquid  phantoms 
[2,7,57,60,61].  For  30%  Intralipid  used  in  this  study,  μsIntralipid  (λ)  is  the  μs  (λ)  of  10% 
Intralipid multiplied by a factor of three [57]. 
2.5. Phantom experimental protocols and data analysis 
μa variation. In this protocol, variation of µa was induced while maintaining a constant µs. 
Thirteen steps were performed to cover µa (830 nm) from 0.05 to 0.20 cm
1 with a step size of 
0.0125 cm
1 (i.e., µa (830 nm) = 0.05, 0.0625, 0.075, …, 0.20 cm
1) and µs (830 nm) = 10 
cm
1.  Prior  to  beginning  the  Imagent  requires  calibration  to  a  phantom  of  known  optical 
properties. During this process, corrections are made to account for the efficiency of optical 
coupling among the lasers/detector, optical fibers, and phantom [45,62]. The Imagent was 
calibrated  to  a  liquid  phantom  of  equivalent  composition  and  optical  properties  at  the 
midpoint (step 7) of the experimental range, i.e., µa (830 nm) = 0.125 cm
1 and µs (830 nm) = 
10 cm
1. The combined probe was then placed upon a liquid phantom at the lowest optical 
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1. For each of 13 steps the following actions were 
taken. Desired volume of ink solution was added to the liquid phantom, mixed, and allowed to 
stabilize for 10 minutes. Viscosity data was attained during this time by extracting three 500 
µl samples. The three samples were carefully taken from the left, right and middle of the 
solution (at the surface) to minimize spatial variations without submerging the pipette. Room 
light was then turned off and the experimental setup was covered with black plastic to reduce 
ambient light. Measurements were taken by the hybrid optical instrument and temperature 
sensor for a 5 minute interval. 
μs  variation.  Variation  of  μs  immediately  followed  the  performing  of  μa  variation 
experiments.  Between  experiments  the  phantom  from  μa  variation  was  disposed  of  and 
replaced with a new initial phantom for μs variation. The hybrid probe was cleaned with 
alcohol pads and repositioned on the surface of the second phantom for μs variation study. 
Neither Imagent nor DCS were shut down between protocols. Variation of µs was induced 
while maintaining a constant µa. A scattering range of µs (830 nm) from 4 to 16 cm
1 with a 
step size of 1 cm
1 (i.e., µs (830 nm) = 4, 5, 6, …, 16 cm
1) and µa (830 nm) = 0.125 cm
1 was 
performed over thirteen steps. The volume of Intralipid required to increase μs as desired 
could potentially reduce μa as well as influence the level of probe submersion. To remedy the 
first difficulty, ink was added with the Intralipid to maintain the µa of the phantom. For the 
second, an equivalent amount of phantom solution was removed after being mixed at each 
step. Viscosity, temperature and hybrid optical measurements were taken similarly to those 
during μa variation. 
Data  analysis  and  presentation.  Each  5  minute  interval  measurement  involves  post 
calculations of interval averages of μa and μs at each wavelength along with the temperature, 
sample average of viscosity, and three diffusion coefficients (DBs). Data between intervals 
(i.e., adding/taking  solution,  stirring) are excluded from data analysis. The µa and µs are 
measured  by  Imagent  using  the  spatially  resolved  (slope)  method  (see  Section  2.2)  and 
averaged  over  the  5  minute  interval.  The  averaged  µa  and  µs  are  then  used  as  known 
parameters in fitting DCS measured g2s using Eq. (1) and (3) to produce two distinct DCS 
DBs, which are distinguished with subscripts describing the optical property values used for 
calculation  of  DB.  The  first  DCS  DB  (DB-mid)  is  calculated  with  the  averaged  µa  and  µs 
measured from the middle interval, i.e., µa (830 nm) = 0.125 cm
1 and µs (830 nm) = 10 cm
1, 
serving as the diffusion coefficient ignorant of optical property variation. Using the constant 
µa  and  µs  from  the  middle  interval  results  in  overestimations  of  µa  and  µs  during  early 
intervals and underestimations at later intervals, thus causing errors in calculation of flow 
indices. The second DCS DB (DB-dynamic) is calculated using the averaged µa and µs measured 
from the corresponding interval, providing the best evaluations of DCS flow indices. These 
DCS DB calculations are repeated for both sets of wavelengths. The optical properties from 
the Imagent measurements at 830 and 780 nm are used in calculations of DCS DB
s at 830 and 
785 nm, respectively. The influence of wavelength mismatch (5 nm) between 780 and 785 nm 
is  considered  to  be  minor.  The  third  DB  (DB-Einstein)  is  calculated  using  Eq.  (4)  with  the 
estimated particle radius, interval averaged temperature and three sample averaged viscosity. 
The estimated particle radius of 196 nm is determined to exhibit the least errors between the 
measured DCS flow indices (DB-dynamic) and calculated DB-Einstein at the calibration point (step 
7). This estimation falls within the range of Intralipid particle size reported in the literatures 
[2,59]. 
Measurement  errors  are  characterized  by  calculating  percentage  errors  between  the 
measured values and predictions. P-values from Student t-tests are included for comparisons 
of measurement errors and the criterion for significance is p < 0.05. Results are presented in 
figures  and  tables  to  visualize  measurement  variations,  differences  between  expected  and 
obtained values, and the optical property influences on DCS flow indices. Data are depicted 
as mean ± standard deviation (SD) in tables and SD is illustrated by error bars in figures. 
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The possible errors of assuming constant optical properties in calculation of flow indices may 
be more readily visualized through analysis of real tissue measurements. In order to evaluate 
such influences in in vivo measurements, tissue hemodynamic properties of head and neck 
tumors in 10 patients were measured using a hybrid optical instrument similar to that in the 
phantom study. Institutional review board (IRB) approval was given by the University of 
Kentucky and consent forms were obtained before subject participation. Only subjects with 
Stage III-IVb Squamous Cell Carcinoma of the Head and Neck (SCCHN) were included. 
Neck lymph nodes measuring more than 1 cm and clinically thought to be involved by tumor 
were selected to study. 
The Imagent used 690 and 830 nm source wavelengths whereas DCS used 785 and 854 
nm  lasers.  Other  wavelengths  used  for  phantom  studies  were  not  available  for  the  tumor 
study. Thus, data from 830 nm for Imagent and 854 nm for DCS are analyzed for this tumor 
study  as  these  wavelengths  provide  the  best  match.  By  contrast,  the  second  pair  of 
wavelengths (785 nm versus 690 nm) is excluded for data analysis due to the significance of 
wavelength mismatch (95 nm). The Imagent source-detector separations used (2.0, 2.5, 3.0, 
and 3.5 cm) are identical to the phantom study. DCS utilized 3 detector fibers at 1.5, 2.4, and 
2.8 cm separations from the two source fibers. The probe was held by hand and secured on the 
subjects in the center of the area identified as tumor node while tumor optical properties and 
DCS  flow  data  were  obtained  for  ~2  minutes.  DCS  data  from  the  2.8  cm  separation  are 
examined, comparable to the tissue region/depth probed by the Imagent. Using different sets 
of optical properties measured by the Imagent, four DCS flow indices for each of 10 subjects 
are calculated and then averaged over the 2-minute measurement interval. The μa and μs are 
averaged over the measurement duration (2 minutes) for each subject and used in calculating 
the first DCS blood flow index (αDB-dynamic), which is considered as a true flow index. The 
minimum,  mean  and  maximum  μa  and  μs  over  10  subjects  are  determined  and  used  for 
calculating the respective remaining three DCS blood flow indices (αDB-min, αDB-mean, and 
αDB-max respectively) for comparisons with the true flow index (αDB-dynamic). Data in figures 
are presented by interval mean ± SD, where SD is depicted by error bars. 
3. Results 
3.1. μa variation 
In order to evaluate the influence of µa variation on flow indices, thirteen steps of liquid 
phantoms were performed to cover µa (830 nm) from 0.05 to 0.20 cm
1 with a step size of 
0.0125 cm
1 while maintaining a constant µs (830 nm) = 10 cm
1. For each step/interval of 
measurements  over  5  minutes,  the  means  and  SDs  of  viscosity  (from  three  samples), 
temperature and calculated DB-Einstein are displayed as data sets (means) and error bars (SDs) in 
Fig. 2. DB-Einstein (see Fig. 2c) is calculated using the measured temperature (see Fig. 2b) per 
interval along with the associated viscosity (see Fig. 2a) and estimated particle radius (196 
nm). 
The  interval  means  and  SDs  (error  bars)  of  μa,  μs,  DB-Einstein,  DB-mid,  and  DB-dynamic 
throughout the 13 steps of μa variation are displayed in Fig. 3. The measured values of μa (see 
Figs.  3a  and  3d)  and  μs  (see  Figs.  3b  and  3e)  at  two  wavelengths  by  the  Imagent  are 
compared to predictions calculated using spectrometer and Mie theory for the evaluation of 
measurement errors, respectively. Two DCS flow indices (DB-mid and DB-dynamic) are compared 
to the DB-Einstein (as a true flow index) for both wavelengths (see Figs. 3c and 3f). The DB-mid or 
DB-dynamic at each wavelength is calculated using the DCS measurement with averaged µa and 
µs from the middle interval [µa (830 nm) = 0.125 cm
1 and µs (830 nm) = 10 cm
1] or from 
the corresponding interval. 
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Fig. 2. Stability of Brownian motion (DB-Einstein) during μa variation, depicted as means ± SDs 
(as  error  bars).  Viscosity  (a)  is  averaged  from  three  samples  corresponding  to  each  step; 
temperature (b) and DB-Einstein (c) are averaged respectively over 5-minute intervals. 
 
Fig. 3. Measured optical properties with calculated DB-Einstein and DCS flow indices during μa 
variation. Left panels represent measurements obtained by Imagent and DCS at 830 nm. Right 
panels show measurements from Imagent at 780 nm and DCS DB calculations corresponding to 
785 nm. All values shown, except predicted μa (a and d) and μs (b and e), are interval means ± 
SDs. Left panels: (a) μa (830 nm), (b) μs (830 nm), and (c) DB-Einstein (830 nm), DB-dynamic (830 
nm), DB-mid (830 nm). Right panels: (d) μa (780 nm), (e) μs (780 nm), and (f) DB-Einstein (785 
nm), DB-dynamic (785 nm), DB-mid (785 nm). 
3.2. μs variation 
Similar to µa variation, a scattering range of µs (830 nm) from 4 to 16 cm
1 with a step size of 
1 cm
1 was performed over thirteen steps while maintaining a constant µa (830 nm) = 0.125 
cm
1. Results for μs variation are plotted in a similar fashion as μa variation (see Section 3.1). 
The means and SDs (error bars) of viscosity (three samples), temperature and calculated DB-
Einstein throughout μs variation are shown in Fig. 4. The interval means and SDs of μa, μs, DB-
Einstein, DB-dynamic, and DB-mid are displayed in Fig. 5. 
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Fig. 4. Stability of Brownian motion (DB-Einstein) during μs variation, depicted as means ± SDs 
(as  error  bars).  Viscosity  (a)  is  averaged  from  three  samples  corresponding  to  each  step; 
temperature (b) and DB-Einstein (c) are averaged respectively over 5-minute intervals. 
 
Fig.  5.  Measured  optical  properties  with  calculated  DB-Einstein  and  flow  indices  during  μs 
variation. Left panels represent measurements obtained by Imagent and DCS at 830 nm. Right 
panels show measurements from Imagent at 780 nm and DCS DB calculations corresponding to 
785 nm. All values shown, except predicted μa (a and d) and μs (b and e), are interval means ± 
SDs. Left panels: (a) μa (830 nm), (b) μs (830 nm), and (c) DB-Einstein (830 nm), DB-dynamic (830 
nm), DB-mid (830 nm). Right panels: (d) μa (780 nm), (e) μs (780 nm), and (f) DB-Einstein (785 
nm), DB-dynamic (785 nm), DB-mid (785 nm). 
3.3. Quantification of μa and μs influences on flow indices 
Influence  of  μa  and  μs  variations  on  DB-Einstein.  Table  1  lists  the  means  ±  SDs  and 
coefficients of variation (CVs) for viscosity, temperature, and DB-Einstein over the entire range 
of μa and μa
 variations, calculated based on the data shown in  Figs. 2 and 4. The CV is 
defined as a percentage of SD/mean, indicating the variation of the mean values over steps. 
The CVs of temperature, viscosity, and DB-Einstein are less than 2.2%, indicating the minor 
influences of μa and μa
 variations on these variables. The DB-Einstein is thus used as a true flow 
index to evaluate the DCS flow measurement errors. 
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Variables 
μa variation     μs variation 
Mean ± SD  CV     Mean ± SD  CV 
Viscosity (cP)  0.98 ± 0.02  1.54%     0.96 ± 0.02  2.12% 
Temperature (°C)  18.61 ± 0.20  1.05%     18.80 ± 0.12  0.64% 
DB-Einstein (cm
2/s)  1.05E-08 ± 1.65E-10  1.57%     1.07E-08 ± 2.25E-10  2.11% 
Mean measurement errors in μa, μs and DCS flow indices. Table 2 lists the means ± 
SDs of absolute percentage errors in measurements of μa, μs, and DCS flow indices (DB-dynamic 
and DB-mid) over the entire range of μa and μa
 variations, calculated based on the data shown in 
Figs. 3 and 5. Absolute percentage error is defined as (|Estimate-True|/True) X 100%. For μa 
and μs, the Imagent measured values are considered estimates while the spectrometer and Mie 
theory,  respectively,  are  used  as  true  values.  For  flow  indices,  DB-dynamic  and  DB-mid  are 
considered estimates and DB-Einstein as true. The measurement errors for μa, μs, and DB-dynamic 
are small, averaging less than ~7%, whereas those of DB-mid are found to be larger, averaging 
up  to  12.89%  and  49.63%  for  μa  and  μs  variations,  respectively.  The  influences  of  μs 
variation can be seen to produce greater percentage errors on flow indices than those of μa 
variation. In Table 2, mean measurement errors between wavelengths are also compared using 
2-sample unequal variance, two-tailed t-tests with significant differences considered for p-
value < 0.05 and denoted with * prefix. Significant differences in mean measurement errors 
between wavelengths are found in μa (p = 0.01) during μa variation and in μs (p = 0.04) during 
μs  variation.  These  differences  between  wavelengths  are  most  likely  associated  with  the 
intrinsic feature of the instrument (Imagent) in detection accuracy at different wavelengths. 
No significant differences in mean measurement errors between wavelengths are found for 
both DB-dynamic and DB-mid. 
Table 2. Imagent/DCS measurement percentage errors at 780/785 nm (upper line) and 
830/830 nm (lower line) 
Variables 
  μa variation (Absolute % Error)     μs variation (Absolute % Error) 
  Mean ± SD  p-value     Mean ± SD  p-value 
μa 
780 nm    3.39 ± 3.07 
*0.01 
   1.86 ± 1.15 
0.23 
830 nm    0.84 ± 0.95     2.86 ± 2.69 
μs 
780 nm    1.93 ± 1.23 
0.54 
   3.14 ± 2.66 
*0.04 
830 nm    1.60 ± 1.50     5.29 ± 2.27 
DB-dynamic 
785 nm    5.52 ± 3.69 
0.28 
   5.84 ± 10.73 
0.83 
830 nm    4.02 ± 3.30     6.58 ± 6.16 
DB-mid 
785 nm    12.89 ± 12.00 
0.64 
   49.63 ± 31.51 
0.81 
830 nm    10.89 ± 8.99     46.76 ± 27.44 
*p-values < 0.05 
Table 3. The p-values for comparisons of the mean measurement errors between DB-dynamic 
and DB-mid 
DB-dynamic vs. DB-mid  μa variation (p-value)  μs variation (p-value) 
785 nm  0.0525  *0.0003 
830 nm  *0.0205  *0.0002 
*p-values < 0.05. 
Table 3 provides p-value results for comparisons of the mean measurement errors of DB-
dynamic and DB-mid at two wavelengths during μa and μs variations. It is apparent that there are 
significant (though it is borderline at 785 nm during μa variation) differences between the 
measuring (DB-dynamic) and assuming (DB-mid) variables; DB-dynamic is more accurate (with less 
measurement errors, see Table 2) than DB-mid. The much lower p-values for μs variation as 
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flow indices. 
 
Influence of μa and μs variations on DCS flow index. Visualization of the influence of 
optical property assumptions at both wavelengths is shown in Fig. 6, overlaying the results 
from both μa and μs variations over 13 steps (see Figs. 3 and 5). The percentage errors for μa 
during μa variation and for μs during μs variation are defined as [(μa –mid  μa -dynamic)/μa -dynamic] 
X 100% and [(μs-mid  μs-dynamic)/μs-dynamic] X 100%, respectively. The subscripts “mid” and 
“dynamic” correspond to assumed constant (middle-interval) and dynamic optical properties. 
For both variations, the percentage DB error between DB-mid and DB-dynamic for each interval is 
defined  as  [(DB-mid    DB-dynamic)/DB-dynamic]  X  100%.  Larger  estimation  errors  in  optical 
properties (μa and μs) generate larger percentage DB errors. Variations in μs have a greater 
influence on percentage DB errors compared to variations in μa. Trends in overestimation and 
underestimation of flow indices due to variations in μa or μs are different. Overestimating and 
underestimating μa results in overestimating and underestimating flow indices, respectively, 
opposite of the trend for μs. Data for both wavelengths are in good agreement and show only 
minor differences. 
 
Fig.  6.  Inaccurate  estimations  (percentage  errors)  of  μa  and  μs  result  in  corresponding 
percentage DB errors between DB-dynamic and DB-mid for both wavelengths. 
3.4. Influence of tissue optical properties on head and neck tumor blood flow index 
The means ± SDs of measured tumor optical properties (μa and μs) and blood flow indices 
(αDB-dynamic, αDB-min, αDB-mean, and αDB-max) along with corresponding percentage errors for 10 
patients  with  head  and  neck  tumors  are  shown  in  Fig.  7.  Patients  are  shown  in  order  of 
increasing αDB-dynamic (as true flow index), designated with a black line, for comparison of 
trend differences when using optical property assumptions (i.e., αDB-min, αDB-mean, and αDB-
max). Note that the patient numbers represent indices to illustrate the trend rather than actual 
patient numbers corresponding to the measurement sequence. The mean optical properties 
over subjects are: μa (830 nm) = 0.12 ± 0.03 cm
1 and μs (830 nm) = 7.80 ± 2.64 cm
1. 
Maximum and minimum optical properties out of all subjects at 830 nm are indicated using 
the red and blue dots, respectively, in Figs. 7a and 7b. DCS blood flow indices calculated 
using DCS data at 854 nm with different optical properties are represented in Fig. 7c. Without 
considering the tissue optical property influence, the trends of flow indices (αDB-min, αDB-mean, 
and αDB-max) are not the same as the true flow index (αDB-dynamic). Percentage αDB errors are 
calculated  between  the  αDB-dynamic  (true)  and  the  estimated  αDB-min,  αDB-mean,  and  αDB-max. 
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278.15%,  αDB-mean  from  39.48  to  149.01%,  and  αDB-max  from  70.26  to  22.59%.  The 
tendency to overestimate or underestimate the blood flow indices follow the same trends as 
shown for μs variation in Fig. 6, supporting that μs has a greater influence on DCS flow 
indices than μa. 
 
Fig. 7. Tumor optical properties measured by Imagent at 830 nm and flow indices measured by 
DCS at 854 nm using 830 nm optical properties. Data were obtained from tumor region for 10 
subjects with head and neck tumors. All values, except percent errors (d), shown are means ± 
SDs. (a) μa (830 nm), (b) μs (830 nm), (c) αDB-dynamic (854 nm), αDB-min (854 nm), αDB-mean (854 
nm) and αDB-max (854 nm), and (d) % Error αDB-min (854 nm), % Error αDB-mean (854 nm) and % 
Error αDB-max (854 nm). Patients are listed in order of increasing αDB-dynamic (854 nm). 
4. Discussion and conclusions 
4.1. μa and μs variation influences on DB-Einstein 
The Einstein-Stokes  formula calculation,  Eq. (4), provides the Einstein diffuse coefficient 
(DB-Einstein) for spherical particles moving in liquid phantoms. The DB-Einstein is determined by 
the temperature and viscosity of the liquid as well as the particle radius of Intralipid in the 
liquid phantoms. Only slight variations are exhibited in overall average temperature (CV < 
1.1%), viscosity (CV < 2.2%), and DB-Einstein (CV < 2.2%) during both μa and μs variations, as 
seen in Table 1 and Figs. 2 and 4. The particle radius of Intralipid should not change during 
both μa and μs variations. The changes in temperature are likely due to room temperature 
increase over the ~4.5 hour experimental durations. These include contributions by heat from 
equipment in the confined room. The cause of small variations in viscosity is likely due to the 
measurement variations by the viscometer. With these small variations in temperature and 
viscosity, it is thus expected that the derived DB-Einstein from Eq. (4) is stable over the large 
variations of optical properties. 
On the other hand, increases of μa (ink concentration) during μa variation are expected to 
have no contribution to DB-Einstein, as ink provides no particle motion. Similarly, increases of 
μs (Intralipid concentration) during μs variation do not show significant influence on DB-
Einstein, which is expected as all scatterers (Intralipid particles) provide equivalent motion in 
liquid phantoms and the ratio of moving scatterers to all scatterers (α) remains unchanged (α = 
1). Due to the independence of optical properties and high stability throughout, DB-Einstein is 
considered  reasonable  as  the  true  flow  index  for  spherical  particles  moving  in  liquid 
phantoms. 
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In  agreement  with  expectations,  ink  contributes  only  to  increasing  the  absorption  of  the 
phantom during μa variation. Additions of equivalent amounts of ink per interval resulted in 
linear increases in μa for both Imagent  wavelengths (see  Figs. 3a and 3d). Only  minimal 
variations  occurred  in  μs  at  both  wavelengths  during  μa  variation  (see  Figs.  3b  and  3e). 
Calibration at the midpoint [μa (830 nm) = 0.125 cm
1, μs (830 nm) = 10 cm
1] may influence 
the  variation  patterns  seen  in  Imagent  measurements.  Intralipid  contributes  linearly  to  μs 
increases, as expected, during μs variation for both Imagent wavelengths (see Figs. 5b and 
5e). The μa stayed relatively constant with minimal variations during μs variation (see Figs. 
5a and 5d). Measured μa and μs during both experiments are consistent with predictions from 
spectrometer  measurements  and  Mie  theory,  respectively.  More  specifically,  the  μs 
measurement errors were less than 6% (see Table 2) for both experiments and wavelengths, 
which are comparable to those obtained from the literature using the Mie theory estimation 
(see Section 2.4) [59]. Overall, average measurement errors of μa and μs were small during μa 
(< 4%) and μs (< 6%) variations (see Table 2), which are in agreement with those found in 
previous studies using frequency-domain spatially resolved NIRS [44,45]. For μa variation, 
significant difference was found between measurement errors of μa at 780 and 830 nm. For μs 
variation, there was significant difference between measurement errors of μs at 780 and 830 
nm. These differences are likely attributable to the intrinsic instrument (Imagent) feature in 
detection accuracy at separate wavelengths. 
Average  measurement  errors  for  DB-dynamic  (<  7%)  compared  to  DB-Einstein  at  both 
wavelengths  are  similar  to  those  obtained  for  optical  properties  (<  6%)  during  both 
experiments (see Table 2), suggesting the influence of optical properties on DB. 
4.3. Resulting DB errors from optical property assumptions 
When using assumed constant optical properties (i.e., middle-interval μa and μs) to calculate 
DB-mid,  mean  DB-mid  measurement  errors  during  μa  (~13%)  and  μs  (~50%)  variations  (see 
Tables 2 and 3) were significantly higher than those of DB-dynamic (~7%). It is evident that the 
influence of μs on the DCS flow index is much greater than that of μa. This result is further 
supported by the great difference in p-values, where p-values during μs variation are much 
less than p-values during μa variation (see Table 3). Also, looking at Fig. 6, the range of DB 
percentage errors for inaccurate estimations of μs is much wider than that for μa. This result is 
expected due to DCS flow indices being derived from light speckle fluctuations, originated 
from photon phase shifts by dynamic scatterers. Upon examination of the K
2 definition (see 
Eq. (3)), μs should have a more significant influence than μa given the μs
2 term along with the 
much larger scattering over absorption (i.e., μs >> μa) in biological tissues and the liquid 
phantoms. No significant difference was found between wavelengths in DB-dynamic and DB-mid 
measurement errors during both experiments (see Table 2). This indicates that wavelength 
may not be a critical factor in determining the importance of optical property influence on DB 
measurement, although further investigations using a large range of wavelengths are needed 
for making a solid conclusion. The trends of DB estimation errors when using DB-mid were 
found to be different between the μa and μs variations (see Figs. 3c, 3f, 5c, 5f and 6). For μa 
variation, overestimated or underestimated μa results in overestimated or underestimated DB. 
By contrast, for μs variation overestimated or underestimated μs results in underestimated or 
overestimated DB. Extreme examples of incorrect estimations of DB can be seen in Fig. 6. 
Overestimation errors of μa up to ~+150% during μa variation resulted in percentage errors up 
to ~+40% and underestimation errors up of ~40% resulted in percentage errors up to ~20%. 
When overestimation errors of μs reach up to ~+175% during μs variation, DB percentage 
errors were up to ~80%. For underestimation errors of μs up to ~35%, DB percentage errors 
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may be affected by the selection of phantom properties for calibration. 
4.4. In vivo tumor study data in comparison to phantom study results 
In the tumor study, measured μa and μs show large variations between subjects (see Figs. 7a 
and 7b). The range of variations, μa (830 nm) from 0.07 to 0.16 cm
1 and μs (830 nm) from 
5.35 to 13.1 cm
1, is within the range studied using liquid phantoms. The influence of the μs 
variations on flow indices was found to be greater than that of μa, supporting the phantom 
study  results.  This  is  exemplified  by  the  trends  shown  in  Fig.  7c.  The  overestimation  of 
optical properties (using maximum μa and μs) leads to underestimation of DCS flow index 
(αDB-max) and underestimation (using minimum μa and μs) leads to overestimation of DCS 
flow index (αDB-min). These are in agreement with the trends of DB estimation errors using 
inaccurate μs in liquid phantoms (see Figs. 5c, 5f and 6). Percentage αDB errors range greatly, 
from ~70% up to ~ +280%, depending on optical properties assumed. Errors in flow indices 
(see Fig. 7d) produce an incorrect observation of trends in the αDB magnitudes among patients 
(see Fig. 7c). It is evident that lack of consideration for optical property influences can lead to 
invalid results in similar studies. 
4.5. Conclusions 
The advent of DCS technology as a safe and quick alternative for measurement of blood flow 
in deep tissues has brought the need to further investigate potential errors, notably by the 
assumption  of  constant  optical  properties,  μa  and  μs.  The  flow  index  produced  by  DCS 
measurement  is  based  on  a  solution  to  the  correlation  diffusion  equation  which  includes 
parameters  of  μa  and  μs.  Utilizing  a  novel  hybrid  optical  equipment  setup,  capable  of 
measuring all three parameters of interest (i.e., flow index, μa, and μs), with liquid phantom 
experimental protocols has made it possible to perform this investigation. The present study 
evaluates the influences of tissue optical properties on DCS flow indices through isolated 
variations of μa and μs in liquid phantoms. It is found that the particle motions in liquid 
phantoms are not influenced by the variations in optical properties, and the usage of Einstein 
particle  Brownian  motion  coefficient  (DB-Einstein)  as  true  flow  index  is  reasonable  for 
comparison  with  DCS  flow  indices.  During  μa  and  μs  variations,  μs  has  a  much  greater 
influence on DCS flow indices than μa, regardless of the wavelengths used. Studies involving 
significant μa and μs changes should concurrently measure flow index and optical properties 
for accurate extraction of blood flow information in tissue. The flow index errors resulted 
from  the  optical  property  assumptions  in  the  tumor  study  elicit  such  need  for  concurrent 
monitoring of optical properties. Incorporation of laser sources at wavelengths beyond those 
tested in this study may be the subject of future investigation. The range of optical properties 
tested in the phantoms may also be extended to encompass a wider variety of tissues. 
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